Changes in the cytokine network through escalating SIRS after heart surgery;Veränderungen des zytokin-netzwerkes bei eskalierendem SIRS nach herzchirurgischen operationen

Anasthesiologie Intensivmedizin Notfallmedizin Schmerztherapie

Volumn 36, Issue 9, 2001, Pages 552-559

  Sablotzki, A ^a   Mann, V ^b   Simm, A ^a   Czeslick, E ^a  

^a MARTIN LUTHER UNIVERSITÄT HALLE WITTENBERG   (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Cardiopulmonary bypass; Interleukins; MODS; Severe SIRS

Indexed keywords

CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; TRANSFORMING GROWTH FACTOR BETA;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIAGNOSTIC VALUE; DISEASE COURSE; EARLY DIAGNOSIS; FEMALE; HIGH RISK PATIENT; HUMAN; IMMUNE RESPONSE; MALE; MULTIPLE ORGAN FAILURE; PATHOPHYSIOLOGY; PATIENT MONITORING; POSTOPERATIVE PERIOD; PROGNOSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TREATMENT OUTCOME;

AGED; ANTIBODY FORMATION; CARDIOPULMONARY BYPASS; CYTOKINES; FEMALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; POSTOPERATIVE COMPLICATIONS; SURVIVORS;

EID: 0034814850     PISSN: 09392661     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2001-17262     Document Type: Article

References (40)

1. Multiple organ failure. Generalized autodestructive inflammation?
2. Complement and the damaging effects of cardiopulmonary bypass
3. Inflammatory response to cardiopulmonary bypass. Mechanisms involved and possible therapeutic strategies
4. The inflammatory response and extracorporal circulation
5. Regional generation of free oxygen radicals during cardiopulmonary bypass in children
6. Evidence of organ damage after cardiopulmonary bypass: The role of elastase and vasoactive mediators
7. Prevention of reperfusion injury in the neonatal heart with leukocyte-depleted blood
8. Alterations of the cytokine network in patients undergoing cardiopulmonary bypass
9. Cytokine and lipid mediator blood concentrations after coronary artery surgery
10. Expression of adhesion and activation molecules on lymphocytes during open-heart surgery with cardiopulmonary bypass
11. Hyperprocalcitoninemia in patients with noninfectious SIRS and pulmonary dysfunction associated with cardiopulmonary bypass
12. Plasma levels of immunoinhibitory cytokines interleukin-10 and transforming growth factor-beta in patients undergoing coronary artery bypass grafting
13. Sir Isaac Newton, sepsis, SIRS, and CARS
14. SIRS - The Systemic Inflammatory Response Syndrome after cardiac operations
15. Early prediction of outcome in score-identified, post-cardiac surgical patients at high risk for sepsis, using soluble tumor necrosis factor receptor p55 concentrations
16. The systemic inflammatory response to cardiopulmonary bypass: Pathophysiological, therapeutic, and pharmacological considerations
17. Systemic inflammatory response syndrome after cardiac operations
18. Defintions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis
19. Evaluaton of definitions and parameters for sepsis assessment in patients after cardiac surgery
20. Cytokine resonses to cardiopulmonary bypass: Lessons learned from cardiac transplantation
21. Systemische entzündungsreaktionen extrakorporaler therapieverfahren (II): Der kardiopulmonale bypass
22. Improved outcome of APACHE 11 score-defined escalating systemic inflammatory response syndrome in patients post cardiac surgery in 1996 compared to 1988-1990: The ESSICS-study pilot project
23. Arterial and venous cytokine response to cardiopulmonary bypass
24. A potential mechanism of vasodilation after warm heart surgery: The temperature-dependent release of cytokines
25. The inflammatory response to cardiopulmonary bypass and its impact on postoperative myocardial function
26. Plasma cytokines and endotoxin levels correlate with survival in patients with the sepsis syndrome
27. Monocyte expression of interleukin-8 in response to oxidant stress
28. IL-18: A th1-inducing, proinflammatory cytokine and new member of the IL-1 family
29. Interleukin-18 and Interleukin-1β: Two cytokine substrates for ICE (caspase-1)
30. Interleukin-18 (IFN-γ-inducing factor) induces IL-1β and IL-8 via TNF-α production from non-CD14+ human blood mononuclear cells
31. Interleukin-12: A proinflammatory cytokine with immuno-regulatory functions that bridge innate resistance and antigen-specific adaptive immunity
32. Detection of interleukin-10 in patients with septic shock
33. A randomized, controlled trial of IL-10 in humans. Inhibition of inflammatory cytokine production and immune responses
34. IL-10 synergizes with IL-4 and transforming growth factor-β to inhibit macrophage cytotoxic activity
35. T helper type 1 development of naive CD4+ T cells requires the coordinate action of interleukin-12 and interferon-γ and is inhibited by transforming growth factor-β
36. Monitoring of the cellular immune system in patients with biventricular assist devices awaiting cardiac transplantation
37. Transient rise in serum interleukin-8 concentration during acute myocardial infarction
38. Phagocytosing neutrophils produce and release high amounts of the neutrophi-activating peptide interleukin-8
39. Murine macrophage secrete interferon gamma upon combined stimulation with interleukin(IL)-12 and IL-18: A novel pathway of autocrine macrophage activation
40. Interleukin-18 (IFN-γ-inducing-factor) induces IL-1β and IL-8 via TNFα production from non-CD14+ human blood mononuclear cells